Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A

Reza Rezaee1, Mansour Poorebrahim2, Saeideh Najafi3

  • 1Ministry of Health and Medical Education, Deputy of Curative Affairs, Budget Administration, Tehran, IR Iran.

Hepatitis Monthly
|September 20, 2016
PubMed
Abstract

Insights

The G145R mutation in hepatitis B surface antigen (HBsAg) alters its structure, reducing immune recognition and antibody binding. This finding aids in developing improved diagnostics and vaccines for hepatitis B virus (HBV).

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • Hepatitis B virus (HBV) vaccine-escape mutations arise in the HBsAg "a" determinant.
  • The G145R mutation is known to evade immune recognition but its structural and immunogenic impacts are understudied.

Purpose of the Study:

  • To investigate the structural and immunogenic consequences of the G145R mutation in HBsAg.
  • To analyze how G145R affects HBsAg's interaction with antibodies.

Main Methods:

  • 3D structure prediction and refinement of wild-type and G145R mutant HBsAg.
  • Analysis of secondary and 3D structural changes using web tools and molecular dynamics simulations.
  • Immunogenic activity assessment via ClusPro docking and IEDB web tool.

Main Results:

  • G145R mutation induces conformational changes in HBsAg antigenic loops, reducing immunogenicity.
  • A new β-strand forms in the "a" determinant, decreasing binding affinity to MAb12.
  • The mutation enhances HBsAg compactness and stability by increasing "a" determinant rigidity.

Conclusions:

  • Findings provide insights for designing novel diagnostic antibodies targeting HBsAg.
  • Results may contribute to the development of more effective hepatitis B vaccines.